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Abstract
Background: The aim of this study was to measure six months compliance to Swedish clinical
guidelines in psychiatric care after an active supported implementation process, using structured
measures derived from the guidelines.
Methods:  In this observational study four psychiatric clinics each participated in active
implementation of the clinical guidelines for the assessment and treatment of depression and
guidelines for assessment and treatment of patients with suicidal behaviours developed by The
Stockholm Medical Advisory Board for Psychiatry. The implementation programme included
seminars, local implementation teams, regular feedback and academic visits. Additionally two clinics
only received the guidelines and served as controls. Compliance to guidelines was measured using
indicators, which operationalised requirements of preferred clinical practice. 725 patient records
were included, 365 before the implementation and 360 six months after.
Results:  Analyses of indicators registered showed that the actively implementing clinics
significantly improved their compliance to the guidelines. The total score differed significantly
between implementation clinics and control clinics for management of depression (mean scores 9.5
(1.3) versus 5.0 (1.5), p < 0.001) as well as for the management of suicide (mean scores 8.1 (2.3)
versus 4.5 (1.9), p < 0.001). No changes were found in the control clinics and only one of the OR
was significant.
Conclusion: Compliance to clinical guidelines measured by process indicators of required clinical
practice was enhanced by an active implementation.
Background
Interest in evidence-based medicine (EBM) has grown
exponentially. The focus has been on helping clinicians,
patients and policy maker to use the best scientific evi-
dence in their decision-making [1]. Several studies stress
the difficulties of implementing EBM and the challenges
of achieving performance change in health care [2-4].
Psychiatric care is changing more rapidly than other areas
of medicine [5]. Variations in the quality of psychiatric
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care, for example in depression treatment, have been
described in psychiatric practice, including gaps between
clinical practice and evidence-based guideline recommen-
dations [6,7]. Clinical guidelines are useful tools to
increase the use of EBM and to implement research find-
ings [8-10]. Successfully implementing clinical guidelines
and changing practices to reflect current evidence is an
important goal and efficient tools are needed to achieve
that goal [11]. There is also a need of continuous feedback
and formal evaluation of guidelines compliance. One way
of evaluating guidelines implementation is to use indica-
tors derived from the clinical guidelines as measures.
When those represent best practice as prescribed by the lit-
erature, or the consensus view of experts, it can be argued
that they also are process measures of the quality of care.
As such, guidelines based indicators are a powerful tool of
monitoring care and identifying areas of clinical care
needing improvement [12]. A recent systematic review by
Weinmann et al. [13] emphasised that there is only a
small number of implementation studies of psychiatric
guidelines. The effects of the guidelines and role of
involvement on improvement were reported to be moder-
ate or limited. Complex multifaceted interventions, spe-
cific psychological methods, feedback and ongoing
support were associated with a more positive outcome
[13].
Health care is an important part of the Swedish welfare
system and the health service act states that all citizens
should have equal access to health care services, regardless
of where they live or their financial situation. Regional
health authorities, the County Councils, own and operate
nearly all hospital and primary care. In the Stockholm
County, representatives of public purchasers and provid-
ers meet in the Stockholm Medical Advisory Board in
order to develop regional clinical guidelines. The shared
aim is to provide high quality care on equal terms for all
county citizens [14,15]. The Stockholm Medical Advisory
Board for Psychiatry in the medical advisory organisation
has developed clinical guidelines for different psychiatric
disorders with the intention to require those to be imple-
mented in all psychiatric clinics in the Stockholm County.
After the publication of the clinical guideline for depres-
sive disorders in 2003, a pilot study was conducted in
order to monitor the implementation. An implementa-
tion programme was initiated based on the regular assess-
ment of outcome and process quality parameters, defined
as above, repeated benchmarking and feedback mecha-
nisms. The implementation process was introduced and
found feasible. This study reports the findings of a quasi-
experiment involving observations before-and-after the
active implementation of clinical guidelines for the care of
depression patients and suicidal patients with a compari-
son group. Guidelines compliance was assessed by identi-
fying predefined measures of requirements of good
practice in patient records.
Methods
The hypothesis to be tested were: the overall depression
care quality score is higher for patients treated in imple-
mentation clinics than in control clinics and the overall
suicidality care quality score is higher for patients treated
in implementation clinics than in control clinics.
Participating clinics
There were six psychiatric departments in Stockholm
County at the time of the study. Before the study started
all heads of psychiatric departments were invited and par-
ticipated in an implementation conference in Stockholm.
Four departments decided to participate in the study, two
in the implementation of guidelines for depression and
two for the guidelines for suicidal behaviours. Six psychi-
atric clinics from the four departments were included.
Two of the clinics only received the guidelines and served
as controls. The duration of the study was six months.
Implementation process at the four intervention clinics
The implementation started with a series of seminars
based on the clinical guidelines that engaged all staff
members. The psychiatrists who had taken part in the
design of the guidelines led the seminars. At each of the
four clinics local multidisciplinary teams of nurses, physi-
cians, counsellors and psychologists were established.
Two of the clinics implemented the clinical guidelines for
assessment and treatment of depression and two clinics
implemented the guidelines for assessment and treatment
of patient with suicidal behaviours. The teams set local
goals and identified needs of education and training after
analyzing the gap between clinical guidelines and ongo-
ing practice. During the process these goals were evaluated
at regular meetings and the clinical guidelines were
refined. A number of indicators operationalising the
guidelines' requirements on good clinical practice were
defined. The presence of those indicators in the patient
records were documented and served as measures of
guidelines adherence. An internal benchmarking using
the registered data was performed at regular intervals. The
clinics reported their results and they were compared to
averages of the other three intervention clinics. The first
author made regular visits to the clinics during the six
months period. In summary the implementation pro-
gramme included multifaceted interventions, seminars,
local implementation teams, regular feedback and aca-
demic visits.
Implementation at the two control clinics
The guidelines were also distributed to the comparison
clinics, but no seminars were conducted and no local
teams were established.BMC Psychiatry 2008, 8:64 http://www.biomedcentral.com/1471-244X/8/64
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Included medical records
Patient records from adult men and women, who had an
ICD-10 or DSM-IV diagnose of depression were eligible
for inclusion in the study on the implementation of the
clinical guidelines for depression [16,17]. Patient records
were randomly selected. From the two intervention clinics
122 records were selected before and 121 records six
months after the start of the implementation process. At
the control clinics 61 records were selected before and 60
records after. For the implementation of the clinical
guidelines for suicide attempters the inclusion criteria
were patient records from adult men and women, which
were appraised at a psychiatric emergency clinic after a
suicide attempt. From the two intervention clinics 121
records were selected before and 120 records six months
after the start of the implementation process. At the con-
trol clinics 61 records were selected before and 60 records
after. The inter-rater reliability revealed a Cohen's Kappa
statistics of 0.92–1.0, lowest for the assessment of the doc-
umentation of treatment plan (care plan).
Measure of compliance
Requirements of recommended practice included in the
regional clinical guidelines for depression and for suicide
attempters released in 2002 and 2003 were used as indi-
cators of compliance [14,15]. Process indicators devel-
oped to assess the quality of care for depression and for
suicidal patient were used. To assess whether the require-
ments were met (and thus the indicator "present") when
interpreting notes in the medical records a modified audit
instrument by Gardulf and Nordström [18] was used.
Absence of data was assumed to indicate that the relevant
activities had not been undertaken. Presence of an indica-
tor was given a score from 0–2, (0 = absence, 1 = present
but not exactly documented according to the definition
and 2 = a clear occurrence). For example a score of one
was given if the suicide assessment were not structured
according to definition and fulfilled the criteria. The scale
was dichotomised into 0 and 1 (1 and 2). Total score for
the guidelines for treatment of depression were 11 points
and 13 for the guidelines for treatment of suicidal behav-
iours.
Indicators from the clinical guidelines for depression
￿ The time between referral and contact is recorded.
￿ Diagnostic assessment: the medical record should
include at least three of the DSM-IV symptoms for Major
Depression [17].
￿ Standardized rating scale: clinical depression assessment
performed using a standardized rating scale.
￿ Diagnostic structured instrument documented, e.g.
Structured Clinical Interview for DSM-IV-TR (SCID) [19].
￿ The use of a standardized rating scale during treatment
for assessment of symptoms and behaviour documented.
￿ Substance/drug abuse assessment performed using
screening instrument e.g. The Alcohol Use Disorders Iden-
tification Test (AUDIT) [20].
￿ Treatment plan (care plan) documented.
￿ Evaluation of outcome included, e.g. documentation of
whether the patient had responded to antidepressive
treatment, achieved symptom remission or reduction of
symptoms between admission and follow-up.
￿ Continuity: ability to provide uninterrupted care over
time measured as numbers of clinicians involved per
patient episode.
￿ Structured suicide assessment using a standardized rat-
ing scale documented.
￿ Antidepressant medication documented, started at the
second visit.
Indicators from the clinical guidelines for suicide 
attempters
All indicators listed above, and the following additional:
￿ Specialist assessment: a documented assessment done
by a senior physician within 24 hours after the suicide
attempt.
￿ Follow-up assessments performed.
￿ Evaluation assessment after discharge documented.
Data collection
Staff from the participating local teams at each clinic
reviewed the medical records and documented the pres-
ence of the indicators of compliance. The first author
instructed them and a consensus meeting was held,
including a calibrating process. The first author used a ran-
dom replicate sample of 40 medical records to assess
inter-rater reliability. In addition, the staff doing reviews
received regular tutoring. The study took place over a six-
month period and the first data collection was performed
in May 2003, before the implementation. The second data
collection took place in November 2003. Data from
administrative information system were used to identify
records that fulfilled the inclusion criteria, and samples
from each clinic were selected at random dates during the
study period. This study were approved by The Central
Ethical Review Board at Karolinska Institutet.BMC Psychiatry 2008, 8:64 http://www.biomedcentral.com/1471-244X/8/64
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Statistical analysis
The data were analysed using the SPSS for Windows, Ver-
sion 15. The inter-rater reliability was analysed by calcu-
lating Cohen's Kappa. The statistical significances of the
differences before and after the implementation were cal-
culated using Chi-square tests. Associations between age,
gender and percentages of patients being treated in
accordance with each indicator was analysed using Pear-
son correlation tests. Age and gender adjusted odds ratios
were calculated in order to analyse the six months compli-
ance after the implementation. Multiple regression analy-
ses was performed to control for age and gender in change
of total scores in intervention and control groups.
Results
Compliance to the guidelines for depressive disorders
At baseline 122 patient records were included at the
implementation clinics and 61 at the control clinics.
There were no age or gender differences between patients
from the intervention and control clinics. The percentages
of patients being treated in accordance with each indicator
at the implementation and control clinics are presented in
Table 1, column 1 and 3. Some of the indicators were
more often recorded in the implementation clinics; acces-
sibility, diagnostic instrument, standardized rating scale
initially and during treatment, substance/drug abuse and
treatment plan. The total score differed significantly
between implementation clinics and control clinics. Mul-
tiple linear regression analysis was used to compare
change in total depression scores in intervention and con-
trol groups controlling for age and gender. The Beta value
was significant for group (Beta = 0.54, p < 0.001), but not
for age (Beta = -0.01, p < 0.9, or gender Beta = 0.08, p <
0.2).
At the six months follow-up 120 new patient records were
included at the implementation clinics and 60 at the con-
trol clinics. There were no gender differences, but the
mean age of the patients was slightly lower at the imple-
mentation clinics (35.4 years (SD 11.4) versus 38.6 years
Table 1: Percentages of patients being treated in accordance with each indicator at baseline before the implementation of clinical 
guidelines.
Guidelines for depressive disorders Guidelines for suicide attempters
Before Percentage, 
(n) implementation 
clinic/control clinic 
n = 122/61
Chisq, p-value After Percentage, 
(n) implementation 
clinic/control clinic 
n = 121/60
Before Percentage, 
(n) implementation 
clinic/control clinic 
n = 121/61
Chisq, p-value After Percentage, 
(n) implementation 
clinic/control clinic 
n = 120/60
Accessibility/wait 
time
77.9(95)/59.0(36) 7.1, 0.01 89.1(106)/53.3(32) 15.7(19)/29.5(18) 4.8, 0.1 14.2(17)/31.7(19)
Diagnostic 
assessment
83.6(102)/88.5(54) ns 97.5(116)/90.0(54) 49.6(60)/26.2(16) 9.1, 0.01 73.3(88)/16.7(10)
Diagnostic 
instrument
12.3(15)/1.6(1) 5.7, 0.02 27.7(33)/0(0) 0(0)/0(0) ns 7.5(9)/0(0)
Standardized rating 
scale
64.8(79)/44.3(27) 7.0, 0.01 91.6(109)/33.3(20) 41.3(50)/27.9(17) 3.2, 0.1 67.5(81)/16.7(10)
Standardized rating 
scale during 
treatment
50.0(61)/24.6(15) 10.8, 0.001 87.4(104)/38.3(23) 16.5(20)/16.4(10) ns 52.5(63)/10.0(6)
Substance/drug 
abuse
46.7(57)/32.8(20) 3.2, 0.1 87.4(105)/53.3(32) 52.1(63)/55.7(34) ns 64.2(77)/56.7(34)
Treatment (care) 
plan
59.8(73)/42.6(26) 4.8, 0.1 87.4(104)/38.3(23) 33.9(41)/44.3(27) ns 67.5(81)/41.7(25)
Evaluation/
outcome
66.4(81)/59.0(36) ns 95.8(114)/55.0(33) 20.7(25)/19.7(12) ns 47.5(57)/8.3(5)
Continuity 77.0(94)/78.7(48) ns 95.0(113)/61.7(37) 86.0(104)/49.2(30) 28.2, 0.001 81.7(98)/31.7(19)
Suicide assessment 40.2(49)/45.9(28) ns 95.8(115)/35.0(21) 55.4(67)/82.0(50) 12.5, 0.001 93.3(112)/73.3(44)
Antidepressant 
medication
54.1(66)/45.9(28) ns 90.8(109)/36.7(22)
Specialist 
assessment
50.4(61)/83.6(51) 18.9, 0.001 85.4(103)/83.3(50)
Follow-up 72.7(88)/75.4(46) ns 88.3(106)/65.0(39)
Evaluation 
assessment
32.2(39)/18.0(11) 4.1, 0.1 64.2(77)/13.3(8)
mean value (SD) t-value, p-value mean value (SD) t-value, p-value
Total score 6.3(1.7)/5.2(1.9) 3.9, 0.001 9.5(1.3)/5.0(1.5) 5.3(2.5)/5.3(2.2) ns 8.1(2.3)/4.5(1.9)BMC Psychiatry 2008, 8:64 http://www.biomedcentral.com/1471-244X/8/64
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(SD 9.6), t = 1.9, df 178, p < 0.1). The only quality indica-
tor that had an association with age was evaluation of out-
come, which was less often registered in patients with
higher age. The percentages and numbers of patients
being treated in accordance with each indicator at follow-
up are presented in Table 1, column 2 and 6. Age and gen-
der adjusted odds ratios for the compliance for each
depression indicator at the implementations clinics at the
six months follow-up is presented in Table 2. The compli-
ance was better in 8 of 11 depression indicators in the
implementation group than the control group. For the
indicator evaluation of outcome analyses were divided in
different age groups (18–34 years (n = 125), 35–49 years
(n = 80) and ≥50 years (n = 37)). In none of the three age
groups the OR was significant. The results from the con-
trol clinics are presented as a comparison and only sub-
stance/drug abuse was significant. The mean score
increased 3.4 in the implementation clinics and decreased
0.2 in the control clinics (t = 19.7, p < 0.001).
Compliance to the guidelines for the management of 
suicide attempters
At baseline 121 patient records were included at the
implementation clinics and at the control clinics 61
records. There were no gender differences but the patients
at the implementation clinics were slightly younger (32.5
years (8 SD 12.2) versus 38.3 years (SD 15.1), t = 2.8, df
180, p < 0.01). The only indicator that differed in registra-
tion was continuity of care giver that was less often
recorded in older patients. The differences between the
implementation clinics and the control clinics in the doc-
umentation of the quality indicators are presented in
Table 1, column 1 and 3. Some of the indicators were
more often recorded in the implementation clinics, diag-
nostic assessment, standardized rating scale initially, eval-
uation and evaluation assessment. Others were more
frequently recorded at the control clinics, accessibility,
substance/drug abuse, suicide and specialist assessment.
The mean score did not differ between implementation
clinics and control clinics. For continuity of care giver sep-
arate analyses were made in three age-groups (18–34, 35–
49 and ≥50 years). There were differences between the
implementation and control clinic in the in the two
younger age-groups but not in the oldest (Chisq 12.4, df
1, p < 0.001, Chisq 19.0, df 1, p < 0.01, ns)
At the six months follow-up 120 patient records were
included at the implementation clinics and at the control
clinics 60 records. There were no age differences, but the
patients at the implementation clinics were more often
females (70.8% versus 58.3%, chisq = 2.8, df 1, p < 0.1)).
The only quality indicator that had an association with
gender was specialist assessment, which was less often reg-
istered in females. The percentages and numbers of
patients being treated in accordance with each indicator at
follow-up is presented in Table 1, column 2 and 6. Age
and gender adjusted odds ratios for the compliance for
each indicator at the implementations clinics at the six
months follow-up are presented in Table 3. For the indi-
cator specialist assessment analyses were divided accord-
ing to gender. In both gender the OR was significant;
females: 3.4(1.7–6.9), males 33.0(6.8–161.3). The results
from the control clinics are presented as a comparison and
none of the OR was significant. The mean score increased
2.8 in the implementation clinics and decreased 0.8 in the
control clinics (t = 9.5, p < 0.001). A similar procedure as
for comparing total depression score was performed for
total suicide scores and the Beta value was significant for
group (Beta = 0.3, p < 0.001, but not for age (Beta = -0.04,
p < 0.4, or gender Beta = 0.03, p < 0.5).
Table 2: The odds ratio of compliance six months after the implementation of clinical guidelines for the management of depression.
Implementation clinics Control clinics
Indicator OR(CI95%) OR(CI95%)
Accessibility/wait time 2.2(1.0–4.7) 0.6(0.3–1.4)
Diagnostic assessment 7.9(2.3–27.8) 1.2(0.4–3.6)
Diagnostic instrument 2.7(1.4–5.4) *
Standardized rating scale 6.2(2.9–13.2) 0.7(0.3–1.4)
Standardized rating scale during treatment 7.1(3.7–13.7) 1.9(0.9–4.1)
Substance/drug abuse 8.1(4.2–15.7) 2.9(1.3–6.6)
Treatment (care) plan 4.9(2.5–9.5) 0.9(0.4–1.9)
Evaluation/outcome 12.4(4.7–32.9) 0.8(0.4–1.7)
Continuity 5.6(2.2–14.2) 0.4(0.2–1.0)
Suicide assessment 34.7(13.2–91.4) 0.6(0.3–1.3)
Antidepressant medication 8.5(4.2–17.5) 0.7 (0.3–1.4)
t-value, p-value t-value, p-value
Total score 16.2, 0.001 ns
*The numbers did not allow calculations.BMC Psychiatry 2008, 8:64 http://www.biomedcentral.com/1471-244X/8/64
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Discussion
This study showed that six months compliance to clinical
guidelines for the treatment of depression and the man-
agement of suicide attempters measured by indicators of
required clinical practice was enhanced by an active
implementation. The clinics, to which the guidelines were
only disseminated, showed no improvement.
A multifaceted intervention including several active strat-
egies is more likely to be effective than a single active strat-
egy [21]. Interactive approaches, such as audit, feedback,
academic detailing seems most effective at changing phy-
sician care and patient outcome, but are insufficient by
them self [22]. Shortell et al. [23] suggested that four
dimensions are needed for a successful implementation,
i.e. process, strategic, cultural, technical and structural.
Our implementation programme included all of those.
The programme consisted of the introduction of regional
mandatory evidence-based clinical guidelines for psychi-
atric disorders in Stockholm County, a top-down strategic
initiative. The programme encouraged the formation of
local teams at the clinics which created interest, engage-
ment and motivation, giving rise to a culture positive to
guidelines implementation. We acted on the knowledge
that without an appropriate organizational culture, only
small, temporary improvements will be possible [23].
Measurements were based on indicators derived from the
guidelines' evidence based requirements of preferred prac-
tice, giving the implementation a clear structure. The use
of the indicators enabled regular feedback on gaps in per-
formance, compared to guidelines, which was strength-
ened by outreach visits by the researcher, an expert on the
guidelines. Conditions for a learning process were created.
These elements of the programme are strategies previously
reported to be useful in implementation [10]. A summary
of the implementation programme is provided in Table 4.
The process indicators used in this study could also be
used to assess the quality of the care documented in
patient records. Analyses of the documentation in this
Table 3: The odds ratio of compliance six months after the implementation of clinical guidelines for the management of suicidal 
patients.
Implementation clinics Control clinics
Indicator OR(CI95%) OR(CI95%)
Accessibility/wait time 0.9(0.4–1.8) 1.1(0.5–2.4)
Diagnostic assessment 2.8(1.6–4.8) 0.6(0.2–1.5)
Diagnostic instrument * *
Standardized rating scale 2.9(1.7–4.9) 0.5(0.2–1.4)
Standardized rating scale during treatment 6.0(3.3–11.2) 0.6(0.2–1.9)
Substance/drug abuse 1.7(1.0–2.8) 1.0(0.5–2.2)
Treatment (care) plan 4.6(2.6–8.1) 0.9(0.4–2.0)
Evaluation/outcome 3.5(2.0–6.2) 0.4(0.1–1.2)
Continuity 0.7(0.4–1.5) 0.5(0.2–1.0)
Suicide assessment 11.5(5.1–25.8) 0.6(0.3–1.5)
Specialist assessment 6.6(3.5–12.6) 0.8(0.3–2.3)
Follow-up 2.9(1.4–5.7) 0.6(0.3–1.4)
Evaluation assessment 3.9(2.2–6.4) 0.7(0.3–1.8)
t-value, p-value t-value, p-value
Total score 9.0, 0.001 -2.1, 0.1
*The numbers did not allow calculations.
Table 4: The four dimensions of the implementation process at intervention and control clinics.
Strategic Cultural Technical Structural
Intervention clinics Mandatory clinical guidelines, 
local implementation teams 
with expert feed-back and 
support
Local groups formed a 
developmental culture by 
following-up their process. 
Engagement, teamwork and 
participation.
Indicators used as identifiers 
of need for change, 
measures of change, audits
Facilitated learning. 
Seminars, regular 
academic detailing
Control clinics Mandatory clinical guidelines No groups Indicators only mentioned in 
the guidelines
None of the above
Strategic × cultural × technical × structural = ResultBMC Psychiatry 2008, 8:64 http://www.biomedcentral.com/1471-244X/8/64
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study showed that the indicators had a high inter-rater
reliability and were easy to use. The study also showed
that the indicators were feasible for audit and feedback as
part of the implementation strategy. The used indicators
are objective measures that can be used by clinicians,
managers and the public when assessing the quality of the
process and the outcome of patient care [24,25]. Her-
mann and Palmer [26] have argued that process measures
may well be used more effectively in metal health care.
In a previous study antidepressant dosage and duration
adequacy have been used as guideline based process indi-
cators to identify if depression care was based on clinical
guidelines [27]. Indicators can be useful in determine the
maintenance of a good standard of psychiatric service,
and in detecting and stimulate solutions to problems
found in service delivery.
This is a small study and the results are based on patient
records and process quality scores only. Therefore, the
study needs to be replicated to confirm that random
change and selection bias have not combined to produce
a spurious result. We plan to do this using other clinics in
a near future. The intervention clinics had all volunteered
to participate and, thus, they probably consisted of the
most motivated and quality-focused in the region, poten-
tially introducing a bias. The fact that indicator documen-
tation for depression patients at base-line was more
frequent among intervention clinics supports that
assumption. When managing suicide attempters the pic-
ture at baseline was mixed, with some indicators more fre-
quently documented in control clinics.
Another limitation was that the study relied on self-
reporting. Local teams at the clinics assessed the patient
records for indicators. However, a supervisor (the first
author) paid regular visits to the clinic, discussing the reg-
istration. A random sample of records was reassessed by
the first author revealing an acceptable inter-rater reliabil-
ity (Kappa 0.92–1.0).
The strengths of the study are its longitudinal nature and
the fact that it was a quasi-experimental involving meas-
ures before-and-after the intervention with a comparison
group. However, the follow-up was only six months and
the long-term impact is unknown.
This implementation model, although promising in the
light of our study, needs to be further tested. In this study
we show that these indicators were easy to use and had
high inter-rater reliability. As indicated in the literature,
they can also be used for quality assessment. The chal-
lenge in all implementation work is to achieve improve-
ment, sustainable over time. We plan to follow-up the
studied clinics to learn more about their guidelines com-
pliance and the effects of using the indicators systemati-
cally. The experiences gained from the local
implementation will contribute to the modification, revi-
sion and adaptation of the guidelines, further enhancing
their perceived usefulness and local application.
Conclusion
The findings in this study suggest that compliance to clin-
ical guidelines measured by indicators of required clinical
practice was enhanced by an active implementation. The
active implementation included four dimensions: strate-
gic, cultural, technical and structural.
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